Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,732 | 559 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,259 | 150 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $927.28 | 65 | $0 (2023) |
| Gilead Sciences, Inc. | $864.98 | 54 | $0 (2024) |
| Janssen Biotech, Inc. | $448.96 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $404.24 | 27 | $0 (2024) |
| GENZYME CORPORATION | $331.13 | 14 | $0 (2024) |
| PFIZER INC. | $323.84 | 21 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $313.87 | 21 | $0 (2024) |
| Celgene Corporation | $308.22 | 20 | $0 (2024) |
| Braintree Laboratories, Inc. | $215.64 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,267 | 71 | ABBVIE INC. ($212.24) |
| 2023 | $1,333 | 75 | AbbVie Inc. ($270.18) |
| 2022 | $1,496 | 90 | ABBVIE INC. ($420.90) |
| 2021 | $1,430 | 93 | AbbVie Inc. ($499.75) |
| 2020 | $806.17 | 54 | AbbVie Inc. ($232.55) |
| 2019 | $811.54 | 59 | AbbVie, Inc. ($180.54) |
| 2018 | $723.90 | 54 | AbbVie, Inc. ($229.76) |
| 2017 | $865.63 | 63 | AbbVie, Inc. ($213.36) |
All Payment Transactions
559 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.55 | General |
| 11/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology | ||||||
| 11/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/12/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.65 | General |
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.07 | General |
| Category: GI | ||||||
| 10/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: GI COLON PREP | ||||||
| 09/10/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Rare Disease | ||||||
| 09/05/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| Category: GI | ||||||
| 08/27/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,343 | 1,437 | $1.0M | $143,806 |
| 2022 | 17 | 1,302 | 1,385 | $976,564 | $142,986 |
| 2021 | 15 | 1,725 | 1,829 | $909,610 | $146,129 |
| 2020 | 17 | 1,495 | 1,601 | $752,275 | $118,786 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 140 | 142 | $198,232 | $29,848 | 15.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 278 | 284 | $239,128 | $21,816 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 208 | $80,496 | $18,363 | 22.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 170 | 172 | $186,448 | $15,687 | 8.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 81 | 81 | $79,866 | $14,499 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 144 | 144 | $48,960 | $11,448 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 158 | $43,450 | $10,510 | 24.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 28 | 29 | $28,594 | $5,217 | 18.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 35 | 36 | $35,496 | $5,169 | 14.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $15,686 | $3,288 | 21.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 19 | $7,828 | $2,651 | 33.9% |
| 43450 | Dilation of esophagus | Facility | 2023 | 80 | 81 | $27,702 | $2,615 | 9.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $10,890 | $1,351 | 12.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 20 | $3,240 | $1,273 | 39.3% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 17 | 17 | $425.00 | $70.55 | 16.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 136 | 136 | $189,856 | $27,660 | 14.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 192 | 193 | $209,212 | $19,481 | 9.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 201 | $74,113 | $19,069 | 25.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 243 | 249 | $209,658 | $18,991 | 9.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 95 | 96 | $94,656 | $17,810 | 18.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 128 | 128 | $40,820 | $9,191 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 127 | $32,300 | $8,065 | 25.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 33 | 33 | $32,538 | $5,707 | 17.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $21,692 | $3,287 | 15.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 29 | $8,816 | $3,039 | 34.5% |
About Dr. William Tanner, M.D
Dr. William Tanner, M.D is a Gastroenterology healthcare provider based in Lawrenceville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114911294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Tanner, M.D has received a total of $8,732 in payments from pharmaceutical and medical device companies, with $1,267 received in 2024. These payments were reported across 559 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($8,732).
As a Medicare-enrolled provider, Tanner has provided services to 5,865 Medicare beneficiaries, totaling 6,252 services with total Medicare billing of $551,707. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Lawrenceville, GA
- Active Since 09/06/2005
- Last Updated 09/25/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1114911294
Products in Payments
- XIFAXAN (Drug) $578.07
- DUPIXENT (Biological) $516.66
- HUMIRA (Biological) $490.59
- STELARA (Biological) $434.19
- XELJANZ (Drug) $323.84
- TRULANCE (Drug) $320.36
- VIBERZI (Drug) $307.14
- Humira (Biological) $293.77
- ZEPOSIA (Drug) $286.97
- RINVOQ (Biological) $282.74
- MAVYRET (Drug) $277.09
- Linzess (Drug) $264.11
- LINZESS (Drug) $247.78
- ENTYVIO (Biological) $212.40
- OCALIVA (Drug) $195.42
- SKYRIZI (Biological) $194.90
- ZENPEP (Drug) $167.08
- OMVOH (Drug) $163.46
- Creon (Drug) $148.23
- DIFICID (Drug) $142.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lawrenceville
Long Nguyen, D.o, D.O
Gastroenterology — Payments: $112,688
Dr. Jyotsna Talapaneni, M.d.,, M.D.,
Gastroenterology — Payments: $11,742
Mark Kukler, D.o, D.O
Gastroenterology — Payments: $8,904
Scott Schorr, M.d, M.D
Gastroenterology — Payments: $8,790
Dr. Jae Nam, Md, MD
Gastroenterology — Payments: $8,550
Dr. Srinivasa Ayinala, Md, MD
Gastroenterology — Payments: $8,149